Literature DB >> 18186845

Complete resolution of recurrent calciphylaxis with long-term intravenous sodium thiosulfate.

Kavitha Subramaniam1, Hilary Wallace, Rajalingam Sinniah, Barry Saker.   

Abstract

A 35-year-old morbidly obese woman on home haemodialysis presented with painful indurated subcutaneous nodules histologically characteristic of calciphylaxis. After failing to respond to conventional treatment, she was commenced on an intravenous infusion of 25 g of sodium thiosulfate three times per week. Two weeks after commencing sodium thiosulfate, the pain resolved completely. By 12 weeks, the lesions had healed and the infusions were ceased. Two months later, skin lesions recurred, but resolved again within 3 months of recommencement of sodium thiosulfate treatment, which was continued for 8 months. The treatment was well tolerated. There has been no recurrence of lesions in the 18 months since the cessation of sodium thiosulfate. Clinical trials to determine the optimum dose and duration of therapy for sodium thiosulfate treatment of calciphylaxis should be given priority because of its high rate of success in treating what is otherwise a severe and mostly lethal condition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18186845     DOI: 10.1111/j.1440-0960.2007.00416.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  9 in total

1.  Sodium Thiosulfate: Calciphylaxis.

Authors:  Joyce A Generali; Dennis J Cada
Journal:  Hosp Pharm       Date:  2015-11-24

2.  Calcific uremic arteriolopathy: an underrecognized entity.

Authors:  Victoria Ann Kumar
Journal:  Perm J       Date:  2011

Review 3.  Calcific uremic arteriolopathy: pathophysiology, reactive oxygen species and therapeutic approaches.

Authors:  Kurt M Sowers; Melvin R Hayden
Journal:  Oxid Med Cell Longev       Date:  2010 Mar-Apr       Impact factor: 6.543

4.  Sodium thiosulfate in the treatment of calciphylaxis.

Authors:  George F Cohen; Nikki S Vyas
Journal:  J Clin Aesthet Dermatol       Date:  2013-05

Review 5.  Sodium thiosulfate in the treatment of calcific uremic arteriolopathy.

Authors:  Georg Schlieper; Vincent Brandenburg; Markus Ketteler; Jürgen Floege
Journal:  Nat Rev Nephrol       Date:  2009-09       Impact factor: 28.314

Review 6.  Calciphylaxis: calcific uremic arteriolopathy and the emerging role of sodium thiosulfate.

Authors:  Melvin R Hayden; David Goldsmith; James R Sowers; Ramesh Khanna
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

7.  Calcific uremic arteriolopathy in peritoneal dialysis populations.

Authors:  Nicholas New; Janaki Mohandas; George T John; Sharad Ratanjee; Helen Healy; Leo Francis; Dwarakanathan Ranganathan
Journal:  Int J Nephrol       Date:  2011-06-27

8.  Treatment of Calciphylaxis in CKD: A Systematic Review and Meta-analysis.

Authors:  Suwasin Udomkarnjananun; Kitravee Kongnatthasate; Kearkiat Praditpornsilpa; Somchai Eiam-Ong; Bertrand L Jaber; Paweena Susantitaphong
Journal:  Kidney Int Rep       Date:  2018-10-09

9.  Epidemiology and Treatment of Calcinosis Cutis: 13 Years of Experience.

Authors:  Lili Róbert; Norbert Kiss; Márta Medvecz; Enikő Kuroli; Miklós Sárdy; Bernadett Hidvégi
Journal:  Indian J Dermatol       Date:  2020 Mar-Apr       Impact factor: 1.494

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.